Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord

Brain Research

Volumn 824, Issue 1, 1999, Pages 105-111

  Catheline, Gwénaëlle ^a   Le Guen, Stéphanie ^a   Besson, Jean Marie ^a  

^a INSERM   (France)

Author keywords

c Fos; Carrageenin; Inflammation; Morphine; Opioid receptor antagonist; Spinal cord

Indexed keywords

BINALTORPHIMINE; CARRAGEENAN; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; MORPHINE; MU OPIATE RECEPTOR; NALTRINDOLE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PROTEIN C FOS; SOMATOSTATIN DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SENSORY NERVE; SPINAL CORD DORSAL HORN;

ANALGESICS, OPIOID; ANIMALS; CARRAGEENAN; HINDLIMB; INFLAMMATION; INJECTIONS, INTRAVENOUS; MALE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SOMATOSTATIN; SPINAL CORD;

EID: 0033119020     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01207-X     Document Type: Article

References (49)

1. Adams J.U., Geller E.B., Adler M.W. Receptor selectivity of icv morphine in the rat cold water tail-flick test. Drug Alcohol Depend. 35:1993;197-202.
2. Besse D., Lombard M.C., Besson J.M. Autoradiographic distribution of mu, delta and kappa opioid binding sites in the superficial dorsal horn, over the rostrocaudal axis of the rat spinal cord. Brain Res. 548:1991;287-291.
3. Besson J.-M., Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67(1):1987;67-186.
4. Bourgoin S., Le Bars D., Clot A.M., Hamon M., Cesselin F. Subcutaneous formalin induces a segmental release of met-enkephalin-like material from the rat spinal cord. Pain. 41:1990;323-329.
5. Broadbear J.H., Stevens Negus S., Butelman E.R., De Costa B.R., Woods J.H. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on κ-opioid agonists in the mouse writhing assay. Psychopharmacology. 115:1994;311-319.
6. V. Chapman, J.-M. Besson, Pharmacological studies of nociceptive systems using the c-Fos immunohistochemical technique: an indicator of noxiously activated spinal neurones, in: The Pharmacology of Pain, 1997, pp. 235-279.
7. Chapman V., Honoré P., Buritova J., Besson J.-M. Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat. Neuroscience. 67(3):1995;731-739.
8. Coggeshall R.E., Carlton S.M. Receptor localization in the mammalian dorsal horn and primary afferent neurons. Brain Res. Rev. 24:1997;28-66.
9. Coggeshall R.E., Zhou S., Carlton S.M. Opioid receptors on peripheral sensory axons. Brain Res. 764:1997;126-132.
10. Dhawan B.N., Cesselin F., Rhaghubir R., Reisine T., Bradley P.B., Porthogese P.S., Hamon M. International union of pharmacology: XII. Classification of opioid receptors. Pharmacol. Rev. 48:1996;567-592.
11. A.H. Dickenson, Where and how do opioids act?, in: G.F. Gebhart, D.L. Hammond, T.S. Jensen (Eds.), Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management, IASP Press, Seattle, 1994, pp. 525-552.
12. Draisci G., Iadarola M.J. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol. Brain Res. 6:1989;31-37.
13. Duggan A.W., North R.A. Electrophysiology of opioids. Pharmacol. Rev. 35(4):1984;219-281.
14. Emmerson P.J., Liu M.-R., Woods J.H., Medzihradsky F. Binding affinity and selectivity of opioids at Mu, Delta and Kappa receptors in monkey brain membranes. J. Pharmacol. Exp. Ther. 271:1994;1630-1637.
15. Gogas K.R., Presley R.W., Levine J.D., Basbaum A.I. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-Fos expression. Neuroscience. 42(3):1991;617-628.
16. Goldstein A., Naidu A. Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36:1989;265-272.
17. Guirimand F., Strimbu-Gozariu M., Willer J.-C., Le Bars D. Effects of mu, delta and kappa opioid antagonists on the depression of a c-fiber reflex by intrathecal morphine and DAGO in the rat. J. Pharmacol. Exp. Ther. 269:1994;1007-1019.
18. Hassan A.H.S., Ableitner A., Stein C., Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience. 55(1):1993;185-195.
19. Honoré P., Buritova J., Besson J.-M. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin. Eur. J. Pharmacol. 272:1995;249-259.
20. Honoré P., Buritova J., Besson J.-M. The effects of morphine on carrageenin-induced spinal c-Fos expression are completely blocked by β-Funaltrexamine, a selective mu opioid receptor antagonist. Brain Res. 732:1996;242-246.
21. Honoré P., Chapman V., Buritova J., Besson J.-M. When is the maximal effect of pre-administered systemic morphine on carrageenin evoked spinal c-Fos expression in the rat? Brain Res. 705:1995;91-96.
22. Honoré P., Chapman V., Buritova J., Besson J.-M. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression. Anesthesiology. 85(1):1996;150-160.
23. Hsu S., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxydase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
24. Jones D.N., Holtzman S.G. Long term kappa-opioid receptor blockade following nor-binaltorphimine. Eur. J. Pharmacol. 215:1992;345-348.
25. V. Kayser, Endogenous opioid systems in the modulation of pain: behavioral studies in rat models of persistent hyperalgesia, in: G.F. Gebhart, D.L. Hammond, T.L. Jensen (Eds.), Progress in Pain Research and Management, IASP Press, Seattle, 1994, pp. 553-568.
26. Le Bars D., Besson J.-M. The spinal site of action of morphine in pain relief: from basic research to clinical applications. Trends Pharmacol. Sci. 2:1981;323-325.
27. Magnan J., Paterson S.J., Tavani A., Kosterlitz H.K. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn-Schmiedeberg's Arch. Pharmacol. 319:1982;197-205.
28. Malmberg A.B., Yaksh T.L. Isobolographic and dose-response analyses of the interaction between intrathecal Mu and Delta agonists: effects of naltrindole and its benzofuran analog (NTB). J. Pharmacol. Exp. Ther. 263:1992;264-275.
29. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29.
30. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dollé P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature. 383:1996;819-823.
31. Matthes H.W.D., Smadja C., Valverde O., Vonescht J.-L., Foutz A., Boudinot E., Denavit-Saubié M., Severini C., Negri L., Roques B.P., Maldonado R., Kieffer B.L. Activity of the δ-receptor is partially reduced whereas activity of the κ-opioid receptor is maintained in mice lacking the μ-receptor. J. Neurosci. 1:1998;7285-7295.
32. Molander C., Xu Q., Grant G. The cytoarchitectonic organization of the spinal cord in the rat: I. The lower thoracic and lumbosacral cord. J. Comp. Neurol. 230:1984;133-141.
33. Noguchi K., Dubner R., Ruda M.A. Preproenkephalin mRNA in spinal dorsal horn neurons is induced by peripheral inflammation and is co-localized with Fos and Fos-related proteins. Neuroscience. 46(3):1992;561-570.
34. Noguchi K., Kowalski K., Traub R., Solodkin A., Iadarola M.J., Ruda M.A. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Mol. Brain Res. 10:1991;227-233.
35. Omote K., Kitahata L.M., Nakatani K., Collins G.J. δ-Receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats. Brain Res. 554:1991;299-303.
36. Ossipov M.H., Kovelowski C.J., Porreca F. The increase in morphine antinociceptive potency produced by carrageenin-induced hindpaw inflammation is blocked by naltrindole, a selective δ-opioid antagonist. Neurosci. Lett. 184:1995;173-176.
37. Ossipov M.H., Kovelowski C.J., Wheeler-Aceto H., Cowan A., Hunter J.C., Lai J., Malan T.P. Jr., Porreca F. Opioid antagonists and antisera to endogenous opioids increase the nociceptive response to formalin: demonstration of an opioid kappa and delta inhibitory tone. J. Pharmacol. Exp. Ther. 277:1996;784-788.
38. Porreca F., Jiang Q., Tallarida R.J. Modulation of morphine antinociception by peripheral (Leu5) enkephalin: a synergistic interaction. Eur. J. Pharmacol. 179:1990;463-468.
39. Sora I., Takahashi N., Funada M., Ujike H., Revay A.S., Donovan D.M., Miner L.L., Uhl G.R. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine induced-analgesia. Proc. Natl. Acad. Sci. USA. 94:1997;1544-1549.
40. C. Stein, Peripheral opioid analgesia: mechanisms and therapeutic applications, in: J.-M. Besson, G. Guilbaud, H. Ollat (Eds.), Peripheral Neurons in Nociception: Physio-pharmacological Aspects, John Libbey Eurotext, Paris, France, 1994, pp. 157-165.
41. Suh H.H., Tseng L.F. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 342:1998;67-71.
42. Takemori A.E., Ho B.Y., Naeseth J.S., Porthoghese P.S. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246:1988;255-258.
43. Takemori A.E., Portoghese P.S. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in β-Funaltrexamine-treated mice. J. Pharmacol. Exp. Ther. 243:1987;91-94.
44. Taylor B.K., Peterson M.A., Basbaum A.I. Continuous intravenous infusion of naloxone does not change behavioral, cardiovascular, or inflammatory responses to subcutaneous formalin in the rat. Pain. 69:1997;171-177.
45. W.D. Willis, R.E. Coggeshall, Sensory Mechanisms of the Spinal Cord, Plenum, New York, 1991.
46. Winter C.A., Risley E.A., Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med. 111:1962;544-547.
47. Wongchanapai W., Tsang B.K., He Z., Ho I.K. Differential involvement of opioid receptors in intrathecal butorphanol-induced analgesia: compared to morphine. Pharmacol. Biochem. Behav. 59:1998;723-727.
48. Yaksh T.L. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol. Scand. 41:1997;94-111.
49. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.